|
Dr. Christoph Burdack
He is co-founder of Priaton GmbH and managing director. He is responsible for key account management, scientific coordination and business strategy.
He completed a doctorate with Prof. Dr. Ivar Ugi, at the Institute of Organic Chemistry, Technical University Munich Germany,
in 2001. During his doctoral work, he contributed to the development of special MCR to synthesize complex bi- and tricyclic Carbapenams. Further he has been working on new ß-lactam-antibiotics.
He is co-author of “Advanced
Macromolecular and Supramolecular Materials and Processes” edited by Kurt E. Geckeler; Kluwer Academic Publishers, January 2003. List of publications.
|